# A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain

> **NCT01586494** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 37 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ULTRAM ER
- **DRUG:** ULTRAM ER

## Key facts

- **NCT ID:** NCT01586494
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2012-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586494, "A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01586494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*